"Michigan Heart is a nationally recognized leader in comprehensive cardiovascular care. Led by a team of physicians and health care professionals, Michigan Heart provides expert and efficient care for their patients. With five convenient locations serving southeast Michigan, Michigan Heart brings state-of the-art care close to home."

During the past decade, Michigan Heart, PC conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan Heart, PC" #1 sponsor was "Abbott" with 1 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Heart, PC" #1 collaborator was "Massachusetts General Hospital" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Biotronik, Inc." with 1 trials as a collaborator, "Blue Cross Blue Shield of Michigan Foundation" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Heart, PC" are "Coronary Artery Disease" (4 trials), "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Heart Failure, Congestive" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Michigan Heart, PC" in a lesser frequency.

Most popular intervention types in "Michigan Heart, PC" are "Device" (6 trials), "Drug" (6 trials), "Diagnostic Test" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Dual Site Pacing" (1 trials), "Echocardiogram guided left ventricular lead placement" (1 trials), "Edoxaban-based Regimen" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Heart, PC" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Michigan Heart, PC". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Michigan Heart, PC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Heart, PC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".